Study of a new cholesterol-lowering tablet (XTYW007)
Part of Digestive system clinical trials.
This study tests a new tablet (XTYW007) to see if it’s safe and helps lower cholesterol. It’s for people with certain LDL cholesterol levels and likely for those who have not responded well to standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You understand the trial and agree to follow the study schedule and rules.
- You and your partner agree to use birth control for 6 months after the last dose.
- You are between 18 and 65 years old.
- You weigh at least 110 pounds (men) or 99 pounds (women), and your BMI is between 18 and 28.
- Your LDL cholesterol (a type of ‘bad’ cholesterol) must be within a specific range — either between 80 and 120 mg/dL (for single-dose part) or above 110 mg/dL (for multiple-dose part).
- You do not smoke more than 5 cigarettes a day, and you haven’t used certain drugs, alcohol, or donated blood recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet called KPC000154 in healthy people to see if it is safe and how the body handles it. It may help develop a treatment for conditions related to high cholesterol.
This trial tests a new medication (QLC7401) for people with high cholesterol that is not well controlled by their current treatment. It aims to see if the drug can help lower LDL-C (bad cholesterol) levels and reduce the risk of heart problems.
This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.
This early-stage study tests a new medicine called MWX205 to see if it's safe and how your body processes it. The medicine is designed to help lower high triglycerides and LDL cholesterol (the 'bad' cholesterol), which can increase heart disease risk.
This trial tests if a new drug, QLC7401, can lower cholesterol in people with high cholesterol who are not on other cholesterol medicines. It may be an option if you have low or medium risk of heart disease and no history of heart problems.
This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.
Hear when a new Non-Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.